MedPath

To compare the effects of two different doses of the drug Magnesium Sulphate when added to the drug Ropivacaine of 0.5% concentration in the block above the clavical in upper limb surgery

Phase 4
Conditions
Health Condition 1: R298- Other symptoms and signs involvingthe nervous and musculoskeletal systems
Registration Number
CTRI/2020/07/026549
Lead Sponsor
Dr Nayana Kashyap
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. American society of Anaesthesiology physical status 1 and 2

2. Scheduled for elective upper limb orthopaedic surgery(forearm and elbow surgery)

3. Informed and written consent to the study

Exclusion Criteria

1. Patient with known hypersensitivity to LA

2. Local infection at the site of the block

3. Patients with known coagulopathy or on anticoagulation therapy

4. Patients with history of cardiac,hepatic,renal disease,respiratory,neurological,psychiatric,neuromuscular disorders

5. Pregnant and lactating patients

6. Patients with morbid obesity

7. Patients with systemic use of corticosteroids for 2 weeks or longer within 6 months of surgery and chronic opioid use

8. Patients who are unable to comprehend the Visual Analogue Scale(VAS)for pain assessment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath